Dr. Ralph Weinstein Contributes to Published Research Study

Dr. Ralph Weinstein contributed to a recently published study from US Oncology Research: “Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer.”